This paper is in the following e-collection/theme issue:

Research Letter (86) Reviews in Dermatology (39) Dermatology (47) Dermatology Health Services Research (51) Patient Education for Skin Conditions (22) Patient-Reported Outcome Measures (PROMs) (294)

Published on in Vol 5, No 2 (2022): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/30737, first published .
Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review

Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review

Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review

Authors of this article:

Adrian Joseph Michel Bailey1 Author Orcid Image ;   Heidi Oi-Yee Li1, 2 Author Orcid Image ;   Mark G Kirchhof2 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Wala-Zielińska K, Świerczyńska-Mróz K, Krajewski P, Nowicka-Suszko D, Krajewska M, Szepietowski J. Endogenous Opioid Imbalance as a Potential Factor Involved in the Pathogenesis of Chronic Kidney Disease-Associated Pruritus in Dialysis Patients. Journal of Clinical Medicine 2023;12(7):2474 View